Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pinar Bulutay

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Molecular Biology Reports|January 16, 2024
Characterization and comparison of insulinoma tumor model and pancreatic damage caused by the tumor, and identification of possible markersAyse Karatug Kacar, Pinar Bulutay, Dilara Aylar, et al.
Journal of Bronchology & Interventional Pulmonology|June 22, 2022
Rapid On-site Evaluation and Final Cytologic Diagnoses Correlation During Endobronchial UltrasonographySinem Iliaz, Benan Caglayan, Pinar Bulutay, et al.
Cancer Cytopathology|June 4, 2014
What is the malignancy risk for atypia of undetermined significance? Three years' experience at a university hospital in TurkeyPinar Uyar Gocun, Esra Karakus, Pinar Bulutay, et al.
American Journal of Clinical Pathology|September 8, 2023
Novel ALK immunohistochemistry assay (clone OTI1A4, Dako) is a sensitive, reliable marker for identifying ALK rearrangements in lung adenocarcinomas: A validation studyOzgur Can Eren, Cisel Aydin Mericoz, Emine Bozkurtlar, et al.
Turkish Journal of Medical Sciences|November 6, 2020
The importance of histological patterns on PD-L1 staining heterogeneity: Should we use pattern-based approach for selecting tumor samples for PD-L1 testing in lung adenocarcinomas?Pinar Bulutay, Pinar Firat, Emine Handan Zeren, et al.
Indian Journal of Pathology & Microbiology|April 20, 2023
<i>STRN-ALK</i> rearranged malignant peritoneal mesothelioma-Presenting with bilateral extensive pelvic masses in a young woman: Mimicking low-grade serous ovarian carcinomaPinar Bulutay, Dogan Vatansever, Cagatay Taskiran, et al.
International Journal of Surgical Pathology|July 8, 2025
Small Samples, Big Insights: PD-L1 Experience of a Tertiary InstitutionNuray Tezcan, Lal Sude Gucer, Aslı Aydın, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 2, 2021
Reproducibility of Morphologic Parameters of the International Endocervical Adenocarcinoma Criteria and Classification System and Correlation With Clinicopathologic Parameters: A Multi-Institutional StudyPinar Bulutay, Nihan Haberal, Özlem Özen, et al.
Nuclear Medicine Communications|April 2, 2021
The prediction of spread through air spaces with preoperative 18F-FDG PET/CT in cases with primary lung adenocarcinoma, its effect on the decision for an adjuvant treatment and its prognostic roleOkan Falay, Fatih Selçukbiricik, Serhan Tanju, et al.
Anti-Cancer Drugs|July 8, 2025
First-line lorlatinib treatment in a 19-year-old patient with ALK-rearranged pulmonary large-cell neuroendocrine carcinoma: a case report and literature reviewFatih Kemik, Pinar Bulutay, Cevat İlteriş Kikili, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Molecular Biology Reports|January 16, 2024
Characterization and comparison of insulinoma tumor model and pancreatic damage caused by the tumor, and identification of possible markersAyse Karatug Kacar, Pinar Bulutay, Dilara Aylar, et al.
Journal of Bronchology & Interventional Pulmonology|June 22, 2022
Rapid On-site Evaluation and Final Cytologic Diagnoses Correlation During Endobronchial UltrasonographySinem Iliaz, Benan Caglayan, Pinar Bulutay, et al.
Cancer Cytopathology|June 4, 2014
What is the malignancy risk for atypia of undetermined significance? Three years' experience at a university hospital in TurkeyPinar Uyar Gocun, Esra Karakus, Pinar Bulutay, et al.
American Journal of Clinical Pathology|September 8, 2023
Novel ALK immunohistochemistry assay (clone OTI1A4, Dako) is a sensitive, reliable marker for identifying ALK rearrangements in lung adenocarcinomas: A validation studyOzgur Can Eren, Cisel Aydin Mericoz, Emine Bozkurtlar, et al.
Turkish Journal of Medical Sciences|November 6, 2020
The importance of histological patterns on PD-L1 staining heterogeneity: Should we use pattern-based approach for selecting tumor samples for PD-L1 testing in lung adenocarcinomas?Pinar Bulutay, Pinar Firat, Emine Handan Zeren, et al.
Indian Journal of Pathology & Microbiology|April 20, 2023
<i>STRN-ALK</i> rearranged malignant peritoneal mesothelioma-Presenting with bilateral extensive pelvic masses in a young woman: Mimicking low-grade serous ovarian carcinomaPinar Bulutay, Dogan Vatansever, Cagatay Taskiran, et al.
International Journal of Surgical Pathology|July 8, 2025
Small Samples, Big Insights: PD-L1 Experience of a Tertiary InstitutionNuray Tezcan, Lal Sude Gucer, Aslı Aydın, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 2, 2021
Reproducibility of Morphologic Parameters of the International Endocervical Adenocarcinoma Criteria and Classification System and Correlation With Clinicopathologic Parameters: A Multi-Institutional StudyPinar Bulutay, Nihan Haberal, Özlem Özen, et al.
Nuclear Medicine Communications|April 2, 2021
The prediction of spread through air spaces with preoperative 18F-FDG PET/CT in cases with primary lung adenocarcinoma, its effect on the decision for an adjuvant treatment and its prognostic roleOkan Falay, Fatih Selçukbiricik, Serhan Tanju, et al.
Anti-Cancer Drugs|July 8, 2025
First-line lorlatinib treatment in a 19-year-old patient with ALK-rearranged pulmonary large-cell neuroendocrine carcinoma: a case report and literature reviewFatih Kemik, Pinar Bulutay, Cevat İlteriş Kikili, et al.
Pageof 2